Evaluation of health-related quality of life in hemolytic uraemic syndrome patients treated with eculizumab: a systematic evaluation on basis of EMPRO.
Mukherjee, Anwesha A
Evaluation of health-related quality of life in hemolytic uraemic syndrome patients treated with eculizumab: a systematic evaluation on basis of EMPRO. [electronic resource] - Renal failure Nov 2018 - 107-118 p. digital
Publication Type: Journal Article; Review; Systematic Review
1525-6049
10.1080/0886022X.2018.1427110 doi
Antibodies, Monoclonal, Humanized--therapeutic use
Atypical Hemolytic Uremic Syndrome--drug therapy
Feasibility Studies
Humans
Patient Reported Outcome Measures
Psychometrics
Quality of Life
Evaluation of health-related quality of life in hemolytic uraemic syndrome patients treated with eculizumab: a systematic evaluation on basis of EMPRO. [electronic resource] - Renal failure Nov 2018 - 107-118 p. digital
Publication Type: Journal Article; Review; Systematic Review
1525-6049
10.1080/0886022X.2018.1427110 doi
Antibodies, Monoclonal, Humanized--therapeutic use
Atypical Hemolytic Uremic Syndrome--drug therapy
Feasibility Studies
Humans
Patient Reported Outcome Measures
Psychometrics
Quality of Life